Related Experiment Video

Updated: May 20, 2026

In Vivo Fiber-Coupled Pre-Clinical Confocal Laser-scanning Endomicroscopy (pCLE) of Hippocampal Capillaries in Awake Mice
09:08

In Vivo Fiber-Coupled Pre-Clinical Confocal Laser-scanning Endomicroscopy (pCLE) of Hippocampal Capillaries in Awake Mice

Published on: April 21, 2023

What we know and would like to know about CDKL5 and its involvement in epileptic encephalopathy

Charlotte Kilstrup-Nielsen1, Laura Rusconi, Paolo La Montanara

  • 1Theoretical and Applied Sciences, Division of Biomedical Research, University of Insubria, 21052 Busto Arsizio, Italy.

Neural Plasticity
|July 11, 2012
PubMed

Insights

Cyclin-dependent kinase-like 5 (CDKL5) mutations cause severe neurodevelopmental disorders. Research highlights CDKL5

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Mutations in the X-linked gene cyclin-dependent kinase-like 5 (CDKL5) are linked to early-onset epileptic encephalopathies.
  • CDKL5 is crucial for brain development, with high expression in the maturing brain.
  • Clinical features include intractable epilepsy, severe developmental delay, hypotonia, and Rett-syndrome-like features.

Purpose of the Study:

  • To review the clinical manifestations of CDKL5 mutations.
  • To explore the regulatory mechanisms and molecular pathways of CDKL5.
  • To hypothesize CDKL5's role in neuronal plasticity.

Main Methods:

  • Literature review of clinical and molecular studies on CDKL5.
  • Analysis of signaling pathways and gene expression regulation.
  • Discussion of evidence supporting a role in neuronal plasticity.

Main Results:

  • CDKL5 mutations are associated with severe neurodevelopmental disorders.
  • CDKL5 regulates neuronal morphology and activity-dependent gene expression.
  • Current research is limited but suggests complex cellular functions.

Conclusions:

  • CDKL5 plays a critical role in brain development and neuronal function.
  • Further research is needed to fully elucidate CDKL5's molecular mechanisms.
  • CDKL5 may be involved in neuronal plasticity, offering potential therapeutic targets.

More Related Videos

Lipidomics and Transcriptomics in Neurological Diseases09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

Ex Vivo Calcium Imaging for Drosophila Model of Epilepsy04:41

Ex Vivo Calcium Imaging for Drosophila Model of Epilepsy

Published on: October 13, 2023

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...